NEA 14 GP, LTD
Insider CIK 1551532 · ILIU 10% owner · MULE 10% owner · TCON 10% owner · APPN 10% owner · MRSN 10% owner · SYBX Director, 10% owner · CERC 10% owner · GRTX 10% owner · LOXO 10% owner · CSPR 10% owner · ADAP 10% owner · IMRA 10% owner · SURF 10% owner · OYST 10% owner · ZFOX 10% owner · CSBR 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYBX SYNLOGIC, INC. | P Buy deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | $0 | 2,640,845 | SEC↗ |
| SYBX SYNLOGIC, INC. | H Expire deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | P Buy deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | — | 2,640,845 | SEC↗ |
| SYBX SYNLOGIC, INC. | H Expire deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | — | 0 | SEC↗ |
| ZFOX ZeroFox Holdings, Inc. | U Tender | 2024-05-13 | 2024-05-15 | 18,068,513 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 5,925,287 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-04-06 | 2022-04-07 | 255,463 | $1.10 | $281.0K | 2,611,050 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-04-05 | 2022-04-07 | 439,088 | $1.07 | $469.8K | 2,866,513 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-25 | 2022-01-25 | 102,952 | $1.47 | $151.3K | 3,305,601 | SEC↗ |
| CSPR Casper Sleep Inc. | U Tender | 2022-01-25 | 2022-01-26 | 6,222,502 | $6.90 | $42.94M | 0 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-24 | 2022-01-25 | 19,984 | $1.55 | $31.0K | 3,408,553 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-21 | 2022-01-25 | 11,622 | $1.67 | $19.4K | 3,428,537 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-20 | 2022-01-20 | 6,295 | $1.81 | $11.4K | 3,440,159 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-19 | 2022-01-20 | 13,412 | $1.82 | $24.4K | 3,446,454 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-18 | 2022-01-20 | 6,848 | $1.89 | $12.9K | 3,459,866 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-14 | 2022-01-14 | 9,707 | $1.91 | $18.5K | 3,466,714 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-13 | 2022-01-14 | 7,209 | $1.93 | $13.9K | 3,476,421 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-12 | 2022-01-14 | 4,634 | $2.02 | $9.4K | 3,483,630 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-11 | 2022-01-11 | 2,409 | $2.04 | $4.9K | 3,488,264 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-10 | 2022-01-11 | 1,751 | $2.00 | $3.5K | 3,490,673 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-07 | 2022-01-11 | 14,600 | $2.08 | $30.4K | 3,492,424 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-06 | 2022-01-06 | 10,257 | $2.16 | $22.2K | 3,507,024 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-05 | 2022-01-06 | 8,200 | $2.25 | $18.4K | 3,517,281 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-04 | 2022-01-06 | 13,459 | $2.34 | $31.5K | 3,525,481 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2022-01-03 | 2022-01-03 | 44,665 | $2.34 | $104.5K | 3,538,940 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-31 | 2022-01-03 | 49,953 | $2.25 | $112.4K | 3,583,605 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-30 | 2022-01-03 | 21,858 | $2.29 | $50.1K | 3,633,558 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-29 | 2021-12-29 | 15,196 | $2.30 | $35.0K | 3,655,416 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-28 | 2021-12-29 | 24,580 | $2.34 | $57.5K | 3,670,612 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-27 | 2021-12-29 | 27,651 | $2.42 | $66.9K | 3,695,192 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-23 | 2021-12-27 | 23,961 | $2.41 | $57.7K | 3,722,843 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-22 | 2021-12-27 | 20,109 | $2.32 | $46.7K | 3,746,804 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-21 | 2021-12-27 | 41,222 | $2.32 | $95.6K | 3,766,913 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-20 | 2021-12-27 | 38,123 | $2.33 | $88.8K | 3,808,135 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-20 | 2021-12-27 | 47,000 | $2.21 | $103.9K | 3,846,258 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-16 | 2021-12-27 | 44,993 | $2.23 | $100.3K | 3,893,258 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-15 | 2021-12-27 | 28,817 | $2.28 | $65.7K | 3,938,251 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-14 | 2021-12-27 | 15,093 | $2.56 | $38.6K | 3,967,068 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-13 | 2021-12-27 | 17,501 | $2.83 | $49.5K | 3,982,161 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-10 | 2021-12-27 | 8,667 | $2.83 | $24.5K | 3,999,662 | SEC↗ |
| IMRA IMARA Inc. | S Sale | 2021-12-09 | 2021-12-27 | 5,666 | $2.95 | $16.7K | 4,008,329 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-09-14 | 2020-09-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-09-14 | 2020-09-16 | 20,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-09-14 | 2020-09-16 | 2,000,000 | — | $0 | 5,959,520 | SEC↗ |
| SURF Surface Oncology, Inc. | S Sale | 2020-05-20 | 2020-05-22 | 420,000 | $3.66 | $1.54M | 2,892,877 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-04-09 | 2020-04-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-04-09 | 2020-04-13 | 40,000 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | J Other | 2020-04-09 | 2020-04-13 | 4,000,000 | — | $0 | 7,959,520 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,625,926 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 15,323,454 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 1,342,780 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 3,538,995 | — | $0 | 3,538,995 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2020-03-16 | 2020-03-16 | 475,000 | $16.00 | $7.60M | 4,013,995 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | X Exercise deriv | 2020-03-06 | 2020-03-10 | 859,375 | — | $0 | 0 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | X Exercise | 2020-03-06 | 2020-03-10 | 859,375 | $5.76 | $4.95M | 2,421,875 | SEC↗ |
| CSBR CHAMPIONS ONCOLOGY, INC. | S Sale | 2020-03-06 | 2020-03-10 | 708,155 | $6.99 | $4.95M | 1,713,720 | SEC↗ |
| CSPR Casper Sleep Inc. | P Buy | 2020-02-10 | 2020-02-12 | 1,250,000 | $12.00 | $15.00M | 6,222,412 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,600,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 1,354,829 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 8,975,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 267,935 | — | $0 | 3,941,381 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 1,774,922 | — | $0 | 1,774,922 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 1,898,524 | — | $0 | 3,673,446 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 416,666 | $12.00 | $5.00M | 4,358,047 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 3,606,282 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 1,061,547 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 1,061,547 | — | $0 | 4,990,287 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 935,000 | $16.00 | $14.96M | 5,925,287 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 3,606,282 | — | $0 | 3,928,740 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | X Exercise deriv | 2019-08-28 | 2020-04-13 | 70,593 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | X Exercise | 2019-08-28 | 2020-04-13 | 70,593 | $0.05 | $3.5K | 11,960,731 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | S Sale | 2019-08-28 | 2020-04-13 | 1,211 | $2.91 | $3.5K | 11,959,520 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2019-03-05 | 2019-03-06 | 3,750,000 | $4.00 | $15.00M | 11,890,138 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-09-07 | 2018-09-10 | 3,000,000 | $1.67 | $5.01M | 82,978,668 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | U Tender | 2018-05-01 | 2018-05-09 | 12,679,970 | — | $0 | 0 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy deriv | 2018-03-27 | 2018-03-27 | 707,964 | $0.13 | $92.0K | 707,964 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2018-03-27 | 2018-03-27 | 707,964 | $2.70 | $1.91M | 3,466,003 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-27 | 2018-03-28 | 6,000,000 | $1.92 | $11.52M | 79,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-26 | 2018-03-28 | 571,164 | $1.90 | $1.09M | 73,978,672 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-23 | 2018-03-23 | 294,090 | $1.95 | $573.5K | 73,407,508 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-22 | 2018-03-23 | 869,574 | $1.90 | $1.65M | 73,113,418 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2018-03-21 | 2018-03-23 | 104,844 | $1.81 | $189.8K | 72,243,844 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 27,242 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 2,724,202 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 2,724,202 | — | $0 | 0 | SEC↗ |
| APPN APPIAN CORP | J Other | 2018-02-13 | 2018-02-15 | 27,242 | — | $0 | 27,242 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2018-01-26 | 2018-01-26 | 410,000 | $9.75 | $4.00M | 4,228,940 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-11-27 | 2017-11-27 | 569,620 | — | $0 | 2,724,202 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2017-11-27 | 2017-11-27 | 569,620 | — | $0 | 569,620 | SEC↗ |
| APPN APPIAN CORP | S Sale | 2017-11-27 | 2017-11-27 | 569,620 | $19.49 | $11.10M | 0 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-11-20 | 2017-11-21 | 2,820,516 | — | $0 | 3,293,822 | SEC↗ |
| APPN APPIAN CORP | C Conversion | 2017-11-20 | 2017-11-21 | 2,820,516 | — | $0 | 2,820,516 | SEC↗ |
| APPN APPIAN CORP | S Sale | 2017-11-20 | 2017-11-21 | 2,820,516 | $19.49 | $54.97M | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | A Award | 2017-08-28 | 2017-08-30 | 3,394,439 | — | $0 | 3,818,940 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 2,216,626 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 18,001,419 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion deriv | 2017-07-03 | 2017-07-06 | 11,931,173 | — | $0 | 0 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | P Buy | 2017-07-03 | 2017-07-06 | 1,000,000 | $15.00 | $15.00M | 8,140,138 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | C Conversion | 2017-07-03 | 2017-07-06 | 7,140,138 | — | $0 | 7,140,138 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-05-31 | 2017-05-31 | 6,114,338 | — | $0 | 6,114,338 | SEC↗ |
| APPN APPIAN CORP | C Conversion deriv | 2017-05-31 | 2017-05-31 | 6,114,338 | — | $0 | 0 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | P Buy | 2017-03-27 | 2017-03-28 | 12,870,000 | $0.70 | $9.01M | 72,139,000 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 2,064,048 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 605,668 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | J Other deriv | 2017-03-22 | 2017-03-22 | 12,679,970 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 8,000,038 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion deriv | 2017-03-22 | 2017-03-22 | 1,689,436 | — | $0 | 0 | SEC↗ |
| MULE MULESOFT, INC | C Conversion | 2017-03-22 | 2017-03-22 | 12,359,190 | — | $0 | 12,679,970 | SEC↗ |
| MULE MULESOFT, INC | J Other | 2017-03-22 | 2017-03-22 | 12,679,970 | — | $0 | 0 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2016-11-29 | 2016-11-29 | 869,565 | $5.75 | $5.00M | 2,758,039 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2016-07-29 | 2016-08-02 | 20,120,724 | — | $0 | 20,120,724 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2016-07-29 | 2016-08-02 | 20,120,724 | $0.10 | $2.01M | 55,418,811 | SEC↗ |
| CERC Cerecor Inc. | C Conversion deriv | 2015-10-20 | 2015-10-20 | 16,638,880 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | C Conversion | 2015-10-20 | 2015-10-20 | 594,245 | — | $0 | 594,245 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | C Conversion deriv | 2015-02-04 | 2015-02-05 | 5,373,396 | — | $0 | 0 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | P Buy | 2015-02-04 | 2015-02-05 | 500,000 | $10.00 | $5.00M | 1,888,474 | SEC↗ |
| TCON Tracon Pharmaceuticals, In | C Conversion | 2015-02-04 | 2015-02-05 | 1,388,474 | — | $0 | 1,388,474 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2014-12-23 | 2014-12-29 | 19,868,965 | — | $0 | 19,868,965 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2014-12-23 | 2014-12-29 | 19,868,965 | $0.10 | $1.99M | 35,298,087 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion deriv | 2014-08-06 | 2014-08-06 | 1,558,651 | — | $0 | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | P Buy | 2013-08-06 | 2014-08-06 | 230,769 | $13.00 | $3.00M | 1,789,420 | SEC↗ |
| LOXO Loxo Oncology, Inc. | C Conversion | 2013-08-06 | 2014-08-06 | 1,558,651 | — | $0 | 1,558,651 | SEC↗ |